New drug study offers hope for back pain sufferers
NCT ID NCT06905288
Summary
This study is observing how well the drug secukinumab works for people in Korea with ankylosing spondylitis, a type of inflammatory back arthritis. It will follow 70 adults who have never tried certain advanced medications for their condition. Researchers will track changes in pain, stiffness, and inflammation over about 7 months to see if the drug helps control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novartis Investigative Site
RECRUITINGJinju, Gyeongsangnam-do, 52727, South Korea
-
Novartis Investigative Site
RECRUITINGBusan, 49201, South Korea
Conditions
Explore the condition pages connected to this study.